ESPERITE

ESP EURONEXT AMSTERDAM
ESP
ESPERITE EURONEXT AMSTERDAM
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

ESP Stock Chart

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Health Services
Industry: Medical/Nursing Services
Esperite NV is a holding company which, engages in regenerative and predictive medicine. It operates through the following segments: Stem Cell, The Cell Factory, Genoma, and Other. The Stem Cell segment focuses on the extraction and storage of adult human stem cells. The Cell Factory segment deals in the research and development. The Genoma segment includes predictive medicine. The Other segment provides other types of products and services. The company was founded by Johan Paul Georges Goossens and Marc Jan Waeterschoot on March 8, 2000 and is headquartered in Zutphen, the Netherlands.

Breaking news